April 15, 2021
CDC advisory panel delays Johnson and Johnson decision
A CDC advisory panel said that it needs more data before providing guidance on Johnson & Johnson’s coronavirus vaccine, delaying its recommendation by at least a week. US health officials recommended pausing use of the vaccine this week due to six reported cases of blood clotting (out of ~7M administered doses).
